Ferdy J. Lejeune - Publications, H-index & Citations

Ferdy J. Lejeune

University of Lausanne

51H指数

179论文数

1.0W被引数

收录论文 30

发表时间

LAPAROSCOPY IN THE DIAGNOSIS OF LIVER METASTASES IN 80 CASES OF MALIGNANT-MELANOMA

ENDOSCOPY

IF12.8

2008-03-17

PREAI

BLEIBERG, H; LAMEIR, E; LEJEUNE, F

Distinctive role of integrin-mediated adhesion in TNF-induced PKB/Akt and NF-κB activation and endothelial cell survival

ONCOGENE

IF7.3

2007-03-19

PREAI

Bieler, G.; Hasmim, M.; Monnier, Y.; Imaizumi, N.; Ameyar, M.; Bamat, J.; Ponsonnet, L.; Choualb, S.; Grell, M.; Goodman, S. L.; Lejeune, F.; Rueegg, C.

Improving drug penetration in tumors by targeting tumor vascularization

TARGETED ONCOLOGY

IF4

2006-04-11

OAAI

Lejeune, Ferdy J.

Antiangiogenic peptides and proteins:: From experimental tools to clinical drugs

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

IF8.3

2006-04-01

PREAI

Rueegg, Curzio; Hasmim, Meriem; Lejeune, Ferdy J.; Alghisi, Gian Carlo

Monitoring multiple angiogenesis-related molecules in the blood of cancer patients shows a correlation between VEGF-A and MMP-9 levels before treatment and divergent changes after surgical vs. conservative therapy

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2005-11-29

OAAI

Zaman, K; Driscoll, R; Hahn, D; Werffeli, P; Goodman, SL; Bauer, J; Leyvraz, S; Lejeune, F; Stupp, R; Rüegg, C

Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2005-03-01

608

OAAI

Speiser, DE; Liénard, D; Rufer, N; Rubio-Godoy, V; Rimoldi, D; Lejeune, F; Krieg, AM; Cerottini, JC; Romero, P

Effector function of human tumor-specific CD8 T cells in melanoma lesions:: A state of local functional tolerance

CANCER RESEARCH

IF16.6

2004-04-15

342

PREAI

Zippelius, A; Batard, P; Rubio-Godoy, V; Bioley, G; Liénard, D; Lejeune, F; Rimoldi, D; Guillaume, P; Meidenbauer, N; Mackensen, A; Rufer, N; Lubenow, N; Speiser, D; Cerottini, JC; Romero, P; Pittet, MJ

Evaluation of melanoma vaccines with molecularly defined antigens by ex vivo monitoring of tumor-specific T cells 通过离体监测肿瘤特异性T细胞评估具有分子定义抗原的黑色素瘤疫苗

SEMINARS IN CANCER BIOLOGY

IF15.7

2003-12-01

PREAI

Speiser, DE; Pittet, MJ; Rimoldi, D; Guillaume, P; Luescher, IF; Liénard, D; Lejeune, F; Cerottini, JC; Romero, P

Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma

IMMUNOLOGICAL REVIEWS

IF8.3

2002-11-13

142

PREAI

Romero, P; Valmori, D; Pittet, MJ; Zippelius, A; Rimoldi, D; Lévy, F; Dutoit, V; Ayyoub, M; Rubio-Godoy, V; Michielin, O; Guillaume, P; Batard, P; Luescher, IF; Lejeune, F; Liénard, D; Rufer, N; Dietrich, PY; Speiser, DE; Cerottini, JC

Clinical use of TNF revisited: improving penetration of anti-cancer agents by increasing vascular permeability

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2002-08-15

OAAI

Lejeune, FJ

On the release and half-life of S100B protein in the peripheral blood of melanoma patients

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2001-11-15

115

OAAI

Ghanem, G; Loir, B; Morandini, R; Sales, F; Lienard, D; Eggermont, A; Lejeune, F

Discrepancy between ELISPOT IFN-γ secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2001-08-21

OAAI

Rubio-Godoy, V; Dutoit, V; Rimoldi, D; Lienard, D; Lejeune, F; Speiser, D; Guillaume, P; Cerottini, JC; Romero, P; Valmori, D

Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patients

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2001-07-01

PREAI

Pittet, MJ; Speiser, DE; Valmori, D; Rimoldi, D; Liénard, D; Lejeune, F; Cerottini, JC; Romero, P

Ex vivo IFN-γ secretion by circulating CD8 T lymphocytes:: Implications of a novel approach for T cell monitoring in infectious and malignant diseases

JOURNAL OF IMMUNOLOGY

IF3.4

2001-06-15

123

OAAI

Pittet, MJ; Zippelius, A; Speiser, DE; Assenmacher, M; Guillaume, P; Valmori, D; Liénard, D; Lejeune, F; Cerottini, JC; Romero, P

Validation of an AAS method for the determination of platinum in biological fluids from patients receiving the oral platinum derivative JM216

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2001-06-01

PREAI

Vouillamoz-Lorenz, S; Bauer, J; Lejeune, F; Decosterd, LA

Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma

JOURNAL OF IMMUNOLOGY

IF3.4

2000-12-15

OAAI

Rimoldi, D; Rubio-Godoy, V; Dutoit, V; Lienard, D; Salvi, S; Guillaume, P; Speiser, D; Stockert, E; Spagnoli, G; Servis, C; Cerottini, JC; Lejeune, F; Romero, P; Valmori, D

High tPA-expression in primary melanoma of the limb correlates with good prognosis

BRITISH JOURNAL OF CANCER

IF6.8

2000-11-01

OAAI

Ferrier, CM; Suciu, S; van Geloof, WL; Straatman, H; Eggermont, AMM; Koops, HS; Kroon, BBR; Lejeune, FJ; Kleeberg, UR; van Muijen, GNP; Ruiter, DJ

Tumor necrosis factor:: clinical use and mechanisms of action

DRUG RESISTANCE UPDATES

IF21.7

2000-10-01

PREAI

Rüegg, C; Dormond, O; Oguey, D; Lejeune, FJ